Lexeo Therapeutics Inc. C... (LXEO)

NASDAQ: LXEO · Real-Time Price · USD

4.63

-0.08 (-1.70%)

At close: May 02, 2025, 3:59 PM

4.78

3.24%

After-hours: May 02, 2025, 05:38 PM EDT

Lexeo Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	531K	568K	653.55K	653.55K	122.55K	85.55K
Cost of Revenue	972K	1.46M	1.92M	1.87M	1.84M	1.35M	893K	798.23K	358K	358K	358K	6.7K
Gross Profit	-972K	-1.46M	-1.92M	-1.87M	-1.84M	-1.35M	-362K	-230.23K	295.55K	295.55K	-235.45K	78.85K
Operating Income	-105.77M	-93.36M	-82.09M	-72.51M	-68.51M	-68.73M	-65.94M	-67.28M	-60.51M	-45.31M	-27.83M	-12.52M
Interest Income	7.58M	7.19M	5.59M	3.83M	2.87M	2.44M	2.41M	2M	1.33M	650.28K	194.28K	17.28K
Pretax Income	-98.33M	-86.6M	-77.22M	-69.42M	-66.39M	-66.78M	-63.73M	-65.43M	-59.28M	-44.7M	-27.64M	-12.5M
Net Income	-98.33M	-86.6M	-77.22M	-69.42M	-66.39M	-66.78M	-63.73M	-65.43M	-59.28M	-44.7M	-27.64M	-12.5M
Selling & General & Admin	31.68M	29.42M	24.33M	20.08M	15.38M	12.43M	12.05M	12.39M	11.99M	8.18M	5.53M	2.45M
Research & Development	74.09M	63.94M	57.76M	52.43M	53.13M	56.31M	54.42M	55.45M	49.16M	37.78M	22.41M	10.15M
Other Expenses	n/a	6K	6K	3K	-1K	-7K	-7K	-4K	n/a	n/a	n/a	n/a
Operating Expenses	105.77M	93.36M	82.09M	72.51M	68.51M	68.73M	66.47M	67.85M	61.16M	45.96M	27.95M	12.6M
Interest Expense	137K	157K	174K	192K	205K	209K	186K	142K	92K	38K	9K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	105.77M	93.36M	82.09M	72.51M	68.51M	68.73M	66.47M	67.85M	61.16M	45.97M	27.95M	12.6M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2	-2	-2	-2
Shares Outstanding (Basic)	33.08M	33.06M	33M	27.98M	53.54M	25.17M	25.17M	25.17M	n/a	25.17M	25.17M	26.65M
Shares Outstanding (Diluted)	33.08M	33.06M	33M	27.98M	53.54M	25.17M	25.17M	25.17M	n/a	25.17M	25.17M	26.65M
EPS (Basic)	-3.12	-2.83	-2.74	-2.63	-2.6	-2.07	-1.95	-2.02	-1.75	-1.75	-1.07	-0.47
EPS (Diluted)	-3.12	-2.83	-2.74	-2.63	-2.6	-2.07	-1.95	-2.02	-1.75	-1.75	-1.07	-0.47
EBITDA	-98.56M	-86.81M	-77.47M	-67.94M	-65.62M	-66.05M	-63.13M	-64.74M	-58.41M	-44.33M	-27.65M	-12.51M
EBIT	-98.2M	-86.44M	-77.04M	-69.23M	-66.19M	-66.57M	-63.54M	-65.29M	-59.2M	-44.68M	-27.65M	-12.52M
Depreciation & Amortization	2M	1.97M	1.92M	1.87M	1.84M	1.8M	1.68M	1.23M	793.7K	348.7K	6.7K	6.7K